Cognitive Decline and Dementia
Cognitive decline and dementia describe the spectrum of acquired loss of memory, language, executive function, and other cognitive domains that becomes increasingly common with age. In geriatric medicine the area spans the continuum from normal age-related changes, through mild cognitive impairment, to the dementia syndromes in which cognitive loss is severe enough to interfere with independent daily function.
Definition
Dementia (major neurocognitive disorder) is an acquired, usually progressive decline in one or more cognitive domains that is severe enough to interfere with independence in everyday activities and is not better explained by delirium or another disorder; cognitive decline more broadly includes milder, pre-dementia stages such as mild cognitive impairment.
Scope
This area orients the reader to how acquired cognitive impairment in older adults is conceptualised, classified, and distinguished from normal ageing and from delirium. It groups four topics: mild cognitive impairment, Alzheimer disease in older adults, the non-Alzheimer dementias, and the potentially reversible causes of cognitive impairment. It is a reference overview and does not provide diagnostic or treatment instructions.
Sub-topics
Core questions
- How is acquired cognitive decline distinguished from normal ageing, delirium, and depression?
- What separates mild cognitive impairment from dementia along the severity continuum?
- Which underlying diseases produce dementia, and how do their clinical profiles differ?
- Which causes of cognitive impairment are potentially reversible and therefore important to identify?
Key concepts
- Cognitive continuum from normal ageing to dementia
- Mild cognitive impairment as an intermediate stage
- Functional impairment as the threshold for dementia
- Aetiological heterogeneity (Alzheimer and non-Alzheimer pathologies)
- Mixed pathology in older brains
- Reversible versus irreversible causes
- Distinction from delirium and depression
Mechanisms
The dementias arise from diverse pathological processes affecting the brain: accumulation of amyloid-beta plaques and tau neurofibrillary tangles in Alzheimer disease, cerebrovascular injury in vascular cognitive impairment, alpha-synuclein deposition in Lewy body disease, and tau or TDP-43 pathology in the frontotemporal disorders. In older adults these processes frequently coexist, so a single clinical dementia syndrome often reflects more than one underlying pathology, and community-based autopsy studies show that mixed pathology accounts for a large share of dementia cases.
Clinical relevance
Recognising where an older adult sits on the cognitive continuum, and what underlies their impairment, shapes how clinicians frame prognosis, identify potentially reversible contributors, and counsel patients and families. This entry describes how the field organises that reasoning; it is educational and is not a substitute for individualised assessment or management.
Epidemiology
Dementia prevalence rises steeply with age and represents a major and growing global health burden, with risk concentrated in late life. The 2020 Lancet Commission frames a substantial proportion of dementia risk as attributable to potentially modifiable factors across the life course, while Alzheimer disease remains the single most common underlying pathology in older populations.
Evidence & guidelines
The area draws on consensus diagnostic frameworks for mild cognitive impairment and the specific dementias and on large epidemiological and commission-level syntheses such as the Lancet Commission reports. These are referenced here to orient the reader rather than to direct care.
History
Senile loss of memory was long regarded as an inevitable part of ageing. Through the twentieth century the dementias were progressively recognised as the expression of specific brain diseases rather than ageing alone, and from the 1990s the concept of mild cognitive impairment formalised an intermediate stage between normal cognition and dementia, reframing decline as a continuum amenable to earlier characterisation.
Debates
- How much of dementia is preventable?
- The Lancet Commission argues that a meaningful fraction of dementia risk is associated with potentially modifiable life-course factors; the precise magnitude and the causal interpretation of these population-attributable estimates remain debated.
Key figures
- Ronald Petersen
- Gill Livingston
- Philip Scheltens
Related topics
Seminal works
- petersen-2011
- scheltens-2016
- livingston-2020
Frequently asked questions
- Is cognitive decline a normal part of ageing?
- Some slowing of processing and minor memory changes accompany normal ageing, but dementia is not normal ageing; it reflects underlying brain disease and is defined by cognitive loss severe enough to impair independent daily function.
- Is all dementia caused by Alzheimer disease?
- No. Alzheimer disease is the most common cause, but vascular, Lewy body, frontotemporal, and mixed pathologies also produce dementia, and in older adults more than one pathology is often present at once.